Teva secures FDA approval for Ajovy to prevent migraine episodes
Teva's (TEVA) Schizophrenia Drug Gets CRL From the FDA
US FDA eases Teva headache with Ajovy approval
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
FDA's Call on Migraine Drug Could Be Trouble for Teva | Barron's
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | Fierce Pharma
Medincell stock drops as FDA hits Teva with CRL on long-acting risperidone | BioWorld
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Teva Hits FDA Hurdle, Slips 4.5% Pre-Market
FDA rejects schizophrenia drug from Teva
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA) | FDA
Teva wins FDA nod for its generic of Mylan's EpiPen after 2-year delay | Fierce Pharma
FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce Pharma
Troubled Teva plant in Hungary faces an FDA crackdown - STAT
Teva Generics: Quality, It's Fundamental.
Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva debuts generics of Delzicol and Tarceva in the USA
Teva Stops Production At US Plant After FDA Concerns: Report
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva recalls single lot of cancer drug topotecan after complaint flags glass particulate in vial | Fierce Pharma
FDA delays approval for Teva schizophrenia drug
